School of Medicine Publications and Presentations

Document Type

Article

Publication Date

12-13-2022

Abstract

Refractory dysphasia could be the main symptom of Antisynthetase syndrome (ASS). IVIG may have a major impact in the successful treatment of dysphasia in patients with ASS. In our patient with ASS, IVIG treatment was an unreplaceable treatment option, and the patient regains her ability to swallow within 2 days.

Comments

© 2022 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.

Publication Title

Clinical Case Reports

DOI

10.1002/ccr3.6569

Academic Level

faculty

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.